EGFR and oligodendroglioma: The amplification and mutation of EGFR has been detected in 40%-50% of GBMs and oligodendrogliomas [40], EGFRvIII, which is a constitutively active EGFR mutant, can be detected in 12%-16% of GBM by IHC.